{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:52:27Z","timestamp":1791273147893,"version":"4.1.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T00:00:00Z","timestamp":1373500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s12017-013-8242-1","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T05:33:11Z","timestamp":1373434391000},"page":"549-569","source":"Crossref","is-referenced-by-count":82,"title":["Nicotine Prevents Synaptic Impairment Induced by Amyloid-\u03b2 Oligomers Through \u03b17-Nicotinic Acetylcholine Receptor Activation"],"prefix":"10.1007","volume":"15","author":[{"given":"Nibaldo C.","family":"Inestrosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Y.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena S.","family":"Arrazola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juvenal A.","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe G.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginny G.","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,11]]},"reference":[{"key":"8242_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1083\/jcb.200511054","volume":"174","author":"A Ahmad-Annuar","year":"2006","unstructured":"Ahmad-Annuar, A., Ciani, L., Simeonidis, I., Herreros, J., Fredj, N. B., Rosso, S. B., et al. (2006). Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release. Journal of Cell Biology, 174, 127\u2013139.","journal-title":"Journal of Cell Biology"},{"key":"8242_CR2","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcp.21902","volume":"221","author":"MS Arr\u00e1zola","year":"2009","unstructured":"Arr\u00e1zola, M. S., Varela-Nallar, L., Colombres, M., Toledo, E. M., Cruzat, F., Pavez, L., et al. (2009). Calcium\/calmodulin-dependent protein kinase type IV is a target gene of the Wnt\/\u03b2-catenin signaling pathway. Journal of Cellular Physiology, 221, 658\u2013667.","journal-title":"Journal of Cellular Physiology"},{"key":"8242_CR3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1471-4159.1992.tb09752.x","volume":"58","author":"I Aubert","year":"1992","unstructured":"Aubert, I., Araujo, D. M., Cecyre, D., Robitaille, Y., Gauthier, S., & Quirion, R. (1992). Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer\u2019s and Parkinson\u2019s diseases. Journal of Neurochemistry, 58, 529\u2013541.","journal-title":"Journal of Neurochemistry"},{"key":"8242_CR4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/exnr.2000.7397","volume":"163","author":"RT Bartus","year":"2000","unstructured":"Bartus, R. T. (2000). On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Experimental Neurology, 163, 495\u2013529.","journal-title":"Experimental Neurology"},{"key":"8242_CR5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus, R. T., Dean, R. L, 3rd, Beer, B., & Lippa, A. S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408\u2013414.","journal-title":"Science"},{"key":"8242_CR6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jnen\/59.4.308","volume":"59","author":"TG Beach","year":"2000","unstructured":"Beach, T. G., Kuo, Y. M., Spiegel, K., Emmerling, M. R., Sue, L. I., Kokjohn, K., et al. (2000). The cholinergic deficit coincides with A\u03b2 deposition at the earliest histopathologic stages of Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 59, 308\u2013313.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"8242_CR7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0197-4580(91)90102-P","volume":"12","author":"JJ Buccafusco","year":"1991","unstructured":"Buccafusco, J. J., & Jackson, W. J. (1991). Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiology of Aging, 12, 233\u2013238.","journal-title":"Neurobiology of Aging"},{"key":"8242_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/pr.108.000562","volume":"61","author":"SD Buckingham","year":"2009","unstructured":"Buckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B. (2009). Nicotinic acetylcholine receptor signalling: roles in Alzheimer\u2019s disease and amyloid neuroprotection. Pharmacological Reviews, 61, 39\u201361.","journal-title":"Pharmacological Reviews"},{"key":"8242_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0079-6123(08)64300-9","volume":"70","author":"JM Candy","year":"1986","unstructured":"Candy, J. M., Perry, E. K., Perry, R. H., Court, J. A., Oakley, A. E., & Edwardson, J. A. (1986). The current status of the cortical cholinergic system in Alzheimer\u2019s disease and Parkinson\u2019s disease. Progress in Brain Research, 70, 105\u2013132.","journal-title":"Progress in Brain Research"},{"key":"8242_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnmol.2011.00019","volume":"4","author":"FJ Carvajal","year":"2011","unstructured":"Carvajal, F. J., & Inestrosa, N. C. (2011). Interactions of AChE with A\u03b2 aggregates in Alzheimer\u2019s brain: Therapeutic relevance of IDN 5706. Frontiers in Molecular Neuroscience, 4, 19.","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"8242_CR11","doi-asserted-by":"crossref","unstructured":"Carvajal, F. J., Zolezzi, J. M., Tapia-Rojas, C., Godoy, J. A., & Inestrosa, N. C. (2013). Tetrahydrohyperforin decreases cholinergic markers associated with amyloid-\u03b2 plaques, 4-hydroxynonenal formation and caspase-3 activation in A\u03b2PP\/PS1 mice. Journal of Alzheimer\u2019s Disease, 36(1), 99\u2013118.","DOI":"10.3233\/JAD-130230"},{"key":"8242_CR12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/156720508784533321","volume":"5","author":"W Cerpa","year":"2008","unstructured":"Cerpa, W., Dinamarca, M. C., & Inestrosa, N. C. (2008a). Structure-function implications in Alzheimer\u2019s disease: effect of A\u03b2 oligomers at central synapses. Current Alzheimer Research, 5, 233\u2013243.","journal-title":"Current Alzheimer Research"},{"key":"8242_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-5-3","volume":"5","author":"W Cerpa","year":"2010","unstructured":"Cerpa, W., Far\u00edas, G. G., Godoy, J. A., Fuenzalida, M., Bonansco, C., & Inestrosa, N. C. (2010). Wnt-5a occludes A\u03b2 oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Molecular Neurodegeneration, 5, 3.","journal-title":"Molecular Neurodegeneration"},{"key":"8242_CR14","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1074\/jbc.M705943200","volume":"283","author":"W Cerpa","year":"2008","unstructured":"Cerpa, W., Godoy, J. A., Alfaro, I., Far\u00edas, G. G., Metcalfe, M. J., Fuentealba, R., et al. (2008b). Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons. Journal of Biological Chemistry, 283, 5918\u20135927.","journal-title":"Journal of Biological Chemistry"},{"key":"8242_CR15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.mp.4001516","volume":"9","author":"MA Chacon","year":"2004","unstructured":"Chacon, M. A., Barr\u00eda, M. I., Soto, C., & Inestrosa, N. C. (2004). \u03b2-sheet breaker peptide prevents A\u03b2-induced spatial memory impairments with partial reduction of amyloid deposits. Molecular Psychiatry, 9, 953\u2013961.","journal-title":"Molecular Psychiatry"},{"key":"8242_CR16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jcp.21497","volume":"217","author":"MA Chacon","year":"2008","unstructured":"Chacon, M. A., Varela-Nallar, L., & Inestrosa, N. C. (2008). Frizzled-1 is involved in the neuroprotective effect of Wnt3a against A\u03b2 oligomers. Journal of Cellular Physiology, 217, 215\u2013227.","journal-title":"Journal of Cellular Physiology"},{"key":"8242_CR17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/35046031","volume":"408","author":"G Chen","year":"2000","unstructured":"Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., et al. (2000). A learning deficit related to age and \u03b2-amyloid plaques in a mouse model of Alzheimer\u2019s disease. Nature, 408, 975\u2013979.","journal-title":"Nature"},{"key":"8242_CR18","doi-asserted-by":"crossref","unstructured":"Codocedo, J. F., Allard, C., Godoy, J. A., Varela-Nallar, L., & Inestrosa, N. C. (2012). SIRT1 regulates dendritic development in hippocampal neurons. PLoS One, 7(10), e47073.","DOI":"10.1371\/journal.pone.0047073"},{"key":"8242_CR19","first-page":"1284","volume":"291","author":"MI Damaj","year":"1999","unstructured":"Damaj, M. I., Glassco, W., Dukat, M., & Martin, B. R. (1999). Pharmacological characterization of nicotine-induced seizures in mice. Journal of Pharmacology and Experimental Therapeutics, 291, 1284\u20131291.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"8242_CR20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies, P., & Maloney, A. J. (1976). Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet, 2, 1403.","journal-title":"Lancet"},{"issue":"10","key":"8242_CR21","doi-asserted-by":"crossref","first-page":"e7524","DOI":"10.1371\/journal.pone.0007524","volume":"4","author":"R Davis","year":"2009","unstructured":"Davis, R., Rizwani, W., Banerjee, S., Kovacs, M., Haura, E., Coppola, D., et al. (2009). Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One, 4(10), e7524.","journal-title":"PLoS One"},{"key":"8242_CR22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.mp.4001208","volume":"8","author":"GV Ferrari De","year":"2003","unstructured":"De Ferrari, G. V., Chac\u00f3n, M. A., Barr\u00eda, M. I., Garrido, J. L., Godoy, J. A., Olivares, G., et al. (2003). Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by \u03b2-amyloid fibrils. Molecular Psychiatry, 8, 195\u2013208.","journal-title":"Molecular Psychiatry"},{"key":"8242_CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fphys.2012.00464","volume":"3","author":"MC Dinamarca","year":"2012","unstructured":"Dinamarca, M. C., R\u00edos, J. A., & Inestrosa, N. C. (2012). Postsynaptic receptors for amyloid-\u03b2 oligomers as mediators of neuronal damage in Alzheimer\u2019s disease. Frontiers in Physiology, 3, 464.","journal-title":"Frontiers in Physiology"},{"key":"8242_CR24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-5-4","volume":"5","author":"MC Dinamarca","year":"2010","unstructured":"Dinamarca, M. C., Sagal, J. P., Quintanilla, R. A., Godoy, J. A., Arr\u00e1zola, M. S., & Inestrosa, N. C. (2010). Amyloid-\u03b2-acetylcholinesterase complexes potentiate neurodegenerative changes induced by the A\u03b2 peptide. Implications for the pathogenesis of Alzheimer\u2019s disease. Molecular Neurodegeneration, 5, 4.","journal-title":"Molecular Neurodegeneration"},{"key":"8242_CR25","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/bi201246t","volume":"5","author":"MC Dinamarca","year":"2011","unstructured":"Dinamarca, M. C., Weistein, D., Monasterio, O., & Inestrosa, N. C. (2011). The synaptic protein neuroligin-1 interacts with the amyloid \u03b2-peptide. Is there a role in Alzheimer\u2019s disease? Biochemistry, 5, 8127\u20138137.","journal-title":"Biochemistry"},{"key":"8242_CR26","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.2741\/2445","volume":"12","author":"KT Dineley","year":"2007","unstructured":"Dineley, K. T. (2007). \u03b2-amyloid peptide\u2013nicotinic acetylcholine receptor interaction: The two faces of health and disease. Frontiers in Bioscience, 12, 5030\u20135038.","journal-title":"Frontiers in Bioscience"},{"key":"8242_CR27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pbb.2011.02.022","volume":"99","author":"JA Dumas","year":"2011","unstructured":"Dumas, J. A., & Newhouse, P. A. (2011). The cholinergic hypothesis of cognitive aging revisited again: Cholinergic functional compensation. Pharmacology, Biochemistry and Behavior, 99, 254\u2013261.","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"8242_CR28","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1523\/JNEUROSCI.6159-08.2009","volume":"29","author":"G Dziewczapolski","year":"2009","unstructured":"Dziewczapolski, G., Glogowski, C. M., Masliah, E., & Heinemann, S. F. (2009). Deletion of the \u03b17 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer\u2019s disease. Journal of Neuroscience, 29, 8805\u20138815.","journal-title":"Journal of Neuroscience"},{"key":"8242_CR29","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1523\/JNEUROSCI.21-20-07993.2001","volume":"21","author":"R Fabian-Fine","year":"2001","unstructured":"Fabian-Fine, R., Skehel, P., Errington, M. L., Davies, H. A., Sher, E., Stewart, M. G., et al. (2001). Ultrastructural distribution of the \u03b17 nicotinic acetylcholine receptor subunit in rat hippocampus. Journal of Neuroscience, 21, 7993\u20138003.","journal-title":"Journal of Neuroscience"},{"key":"8242_CR30","doi-asserted-by":"crossref","first-page":"15857","DOI":"10.1074\/jbc.M808986200","volume":"284","author":"GG Far\u00edas","year":"2009","unstructured":"Far\u00edas, G. G., Alfaro, I. E., Cerpa, W., Grabowski, C. P., Godoy, J. A., Bonansco, C., et al. (2009). Wnt-5a\/JNK signaling promotes the clustering of PSD-95 in hippocampal neurons. Journal of Biological Chemistry, 284, 15857\u201315866.","journal-title":"Journal of Biological Chemistry"},{"key":"8242_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nbd.2004.07.016","volume":"17","author":"GG Farias","year":"2004","unstructured":"Farias, G. G., Godoy, J. A., Hern\u00e1ndez, F., Avila, J., Fisher, A., & Inestrosa, N. C. (2004). M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway. Neurobiology of Diseases, 17, 337\u2013348.","journal-title":"Neurobiology of Diseases"},{"key":"8242_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1523\/JNEUROSCI.3934-06.2007","volume":"27","author":"GG Farias","year":"2007","unstructured":"Farias, G. G., Vall\u00e9s, A. S., Colombres, M., Godoy, J. A., Toledo, E. M., Lukas, R. J., et al. (2007). Wnt-7a induces presynaptic colocalization of \u03b17-nicotinic acetylcholine receptors and adenomatous polyposis coli in hippocampal neurons. Journal of Neuroscience, 27, 313\u20135325.","journal-title":"Journal of Neuroscience"},{"key":"8242_CR33","doi-asserted-by":"crossref","first-page":"37006","DOI":"10.1074\/jbc.M700447200","volume":"282","author":"K Fuenzalida","year":"2006","unstructured":"Fuenzalida, K., Quintanilla, R., Ramos, P., Piderit, D., Fuentealba, R. A., Martinez, G., et al. (2006). Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. Journal of Biological Chemistry, 282, 37006\u201337015.","journal-title":"Journal of Biological Chemistry"},{"key":"8242_CR34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","volume":"24","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., et al. (2006). Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease. Neurobiology of Diseases, 24, 516\u2013524.","journal-title":"Neurobiology of Diseases"},{"key":"8242_CR35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0079-6123(08)62493-0","volume":"79","author":"E Giacobini","year":"1989","unstructured":"Giacobini, E., DeSarno, P., Clark, B., & McIlhany, M. (1989). The cholinergic receptor system of the human brain: Neurochemical and pharmacological aspects in aging and Alzheimer. Progress in Brain Research, 79, 335\u2013343.","journal-title":"Progress in Brain Research"},{"key":"8242_CR36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ceca.2008.10.003","volume":"45","author":"D Gilbert","year":"2009","unstructured":"Gilbert, D., Lecchi, M., Arnaudeau, S., Bertrand, D., & Demaurex, N. (2009). Local and global calcium signals associated with the opening of neuronal alpha7 nicotinic acetylcholine receptors. Cell Calcium, 45, 198\u2013207.","journal-title":"Cell Calcium"},{"key":"8242_CR37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","volume":"65","author":"CA Grimes","year":"2001","unstructured":"Grimes, C. A., & Jope, R. S. (2001). The multifaceted roles of glycogen synthase kinase 3\u03b2 in cellular signaling. Progress in Neurobiology, 65, 391\u2013426.","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"8242_CR38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A., & Higgins, G. A. (1992). Alzheimer\u2019s disease: The amyloid cascade hypothesis. Science, 256(1), 184\u2013185.","journal-title":"Science"},{"key":"8242_CR39","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1523\/JNEUROSCI.5038-09.2010","volume":"30","author":"CM Hernandez","year":"2010","unstructured":"Hernandez, C. M., Kayed, R., Zheng, H., Sweatt, J. D., & Dineley, K. T. (2010). Loss of \u03b17 nicotinic receptors enhances \u03b2-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer\u2019s disease. Journal of Neuroscience, 30, 2442\u20132453.","journal-title":"Journal of Neuroscience"},{"key":"8242_CR40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn2755","volume":"11","author":"NC Inestrosa","year":"2010","unstructured":"Inestrosa, N. C., & Arenas, E. (2010). Emerging roles of Wnts in the adult nervous system. Nature Reviews Neuroscience, 11, 77\u201386.","journal-title":"Nature Reviews Neuroscience"},{"key":"8242_CR41","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s11481-012-9417-5","volume":"7","author":"NC Inestrosa","year":"2012","unstructured":"Inestrosa, N. C., Montecinos-Oliva, C., & Fuenzalida, M. (2012). Wnt signaling: Role in Alzheimer disease and schizophrenia. Journal of Neuroimmune Pharmacology, 7, 788\u2013807.","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"8242_CR42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cell.2011.12.038","volume":"149","author":"M Jensen","year":"2012","unstructured":"Jensen, M., Hoerndli, F. J., Brockie, P. J., Wang, R., Johnson, E., Maxfield, D., et al. (2012). Wnt signaling regulates acetylcholine receptor translocation and synaptic plasticity in the adult nervous system. Cell, 149, 173\u2013187.","journal-title":"Cell"},{"key":"8242_CR43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jnr.10022","volume":"66","author":"RR Jonnala","year":"2001","unstructured":"Jonnala, R. R., & Buccafusco, J. J. (2001). Relationship between the increased cell surface \u03b17 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. Journal of Neuroscience Research, 66, 565\u2013572.","journal-title":"Journal of Neuroscience Research"},{"key":"8242_CR44","doi-asserted-by":"crossref","first-page":"13541","DOI":"10.1074\/jbc.M008035200","volume":"276","author":"T Kihara","year":"2001","unstructured":"Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., et al. (2001). \u03b17 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A\u03b2-amyloid-induced neurotoxicity. Journal of Biological Chemistry, 276, 13541\u201313546.","journal-title":"Journal of Biological Chemistry"},{"key":"8242_CR45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.410420205","volume":"42","author":"T Kihara","year":"1997","unstructured":"Kihara, T., Shimohama, S., Sawada, H., Kimura, J., Kume, T., Kochiyama, H., et al. (1997). Nicotinic receptor stimulation protects neurons against \u03b2-amyloid toxicity. Annals of Neurology, 42, 159\u2013163.","journal-title":"Annals of Neurology"},{"key":"8242_CR46","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","volume":"24","author":"PN Lacor","year":"2004","unstructured":"Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., et al. (2004). Synaptic targeting by Alzheimer\u2019s-related amyloid \u03b2 oligomers. Journal of Neuroscience, 24, 10191\u201310200.","journal-title":"Journal of Neuroscience"},{"key":"8242_CR47","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor, P. N., Buniel, M. C., Furlow, P. W., Clemente, A. S., Velasco, P. T., Wood, M., et al. (2007). A\u03b2 oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. Journal of Neuroscience, 27, 796\u2013807.","journal-title":"Journal of Neuroscience"},{"key":"8242_CR48","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., et al. (1998). Diffusible, nonfibrillar ligands derived from A\u03b2 1\u201342 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America, 95, 6448\u20136453.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8242_CR49","doi-asserted-by":"crossref","first-page":"18543","DOI":"10.1074\/jbc.M414112200","volume":"280","author":"CC Lee","year":"2005","unstructured":"Lee, C. C., Huang, C. C., Wu, M. Y., & Hsu, K. S. (2005). Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. Journal of Biological Chemistry, 280, 18543\u201318550.","journal-title":"Journal of Biological Chemistry"},{"key":"8242_CR50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesn\u00e9","year":"2006","unstructured":"Lesn\u00e9, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., et al. (2006). A specific amyloid-\u03b2 protein assembly in the brain impairs memory. Nature, 440, 352\u2013357.","journal-title":"Nature"},{"key":"8242_CR51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002130050750","volume":"140","author":"ED Levin","year":"1998","unstructured":"Levin, E. D., Conners, C. K., Silva, D., Hinton, S. C., Meck, W. H., March, J., et al. (1998). Transdermal nicotine effects on attention. Psychopharmacology, 140, 135\u2013141.","journal-title":"Psychopharmacology"},{"issue":"3\u20134","key":"8242_CR52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130050667","volume":"138","author":"ED Levin","year":"1998","unstructured":"Levin, E. D., & Simon, B. B. (1998). Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berlin), 138(3\u20134), 217\u2013230.","journal-title":"Psychopharmacology (Berlin)"},{"key":"8242_CR53","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","volume":"2","author":"H LeVine 3rd","year":"1993","unstructured":"LeVine, H, 3rd. (1993). Thioflavine T interaction with synthetic Alzheimer\u2019s disease \u03b2-amyloid peptides: Detection of amyloid aggregation in solution. Protein Science, 2, 404\u2013410.","journal-title":"Protein Science"},{"issue":"8","key":"8242_CR54","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1073\/pnas.081553598","volume":"98","author":"Q Liu","year":"2001","unstructured":"Liu, Q., Kawai, H., & Berg, D. K. (2001). \u03b2-amyloid peptide blocks the response of \u03b17-containing nicotinic receptors on hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America, 98(8), 4734\u20134739.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8242_CR55","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., et al. (1999). Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. American Journal of Pathology, 155, 853\u2013862.","journal-title":"American Journal of Pathology"},{"issue":"3","key":"8242_CR56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0304-3940(02)00546-3","volume":"328","author":"A Marutle","year":"2002","unstructured":"Marutle, A., Unger, C., Hellstr\u00f6m-Lindahl, E., Wang, J., Puoliv\u00e4li, J., Tanila, H., et al. (2002). Elevated levels of A\u03b21-40 and A\u03b21-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice. Neuroscience Letters, 328(3), 269\u2013272.","journal-title":"Neuroscience Letters"},{"key":"8242_CR57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF00293464","volume":"81","author":"E Masliah","year":"1991","unstructured":"Masliah, E., Hansen, L., Albright, T., Mallory, M., & Terry, R. D. (1991). Immunoelectron microscopic study of synaptic pathology in Alzheimer\u2019s disease. Acta Neuropathologica, 81, 428\u2013433.","journal-title":"Acta Neuropathologica"},{"key":"8242_CR58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00445560","volume":"99","author":"SR McGurk","year":"1989","unstructured":"McGurk, S. R., Levin, E. D., & Butcher, L. L. (1989). Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs. Psychopharmacology (Berlin), 99, 371\u2013373.","journal-title":"Psychopharmacology (Berlin)"},{"key":"8242_CR59","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., et al. (1999). Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Annals of Neurology, 46, 860\u2013866.","journal-title":"Annals of Neurology"},{"key":"8242_CR121","doi-asserted-by":"crossref","unstructured":"Melo, J. B., Sousa, C., Gar\u00e7\u00e3o, P., Oliveira, C. R., & Agostinho, P. (2009). Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons. European Journal of Neuroscience, 29(3), 455\u2013464.","DOI":"10.1111\/j.1460-9568.2009.06612.x"},{"key":"8242_CR60","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0196-9781(02)00058-X","volume":"23","author":"C Morgan","year":"2002","unstructured":"Morgan, C., Bugue\u00f1o, M. P., Garrido, J., & Inestrosa, N. C. (2002). Laminin affects polymerization, depolymerization and neurotoxicity of A\u03b2 peptide. Peptides, 23, 1229\u20131240.","journal-title":"Peptides"},{"key":"8242_CR61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pneurobio.2004.10.004","volume":"74","author":"C Morgan","year":"2004","unstructured":"Morgan, C., Colombres, M., Nu\u00f1ez, M. T., & Inestrosa, N. C. (2004). Structure and function of amyloid in Alzheimer\u2019s disease. Progress in Neurobiology, 74, 323\u2013349.","journal-title":"Progress in Neurobiology"},{"key":"8242_CR62","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1098\/rstb.2001.0945","volume":"356","author":"RG Morris","year":"2001","unstructured":"Morris, R. G. (2001). Episodic-like memory in animals: psychological criteria, neural mechanisms and the value of episodic-like tasks to investigate animal models of neurodegenerative disease. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences, 356, 1453\u20131465.","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological sciences"},{"key":"8242_CR63","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejphar.2008.01.051","volume":"585","author":"TJ Nelson","year":"2008","unstructured":"Nelson, T. J., Sun, M. K., Hongpaisan, J., & Alkon, D. L. (2008). Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. European Journal of Pharmacology, 585, 76\u201387.","journal-title":"European Journal of Pharmacology"},{"key":"8242_CR64","doi-asserted-by":"crossref","first-page":"15625","DOI":"10.1073\/pnas.1005807107","volume":"107","author":"E Okun","year":"2010","unstructured":"Okun, E., Griffioen, K., Barak, B., Roberts, N. J., Castro, K., Pita, M. A., et al. (2010). Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proceedings of the National Academy of Sciences of the United States of America, 107, 15625\u201315630.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"8242_CR65","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0006-3223(02)01417-8","volume":"52","author":"K Ono","year":"2002","unstructured":"Ono, K., Hasegawa, K., Yamada, M., & Naiki, H. (2002). Nicotine breaks down preformed Alzheimer\u2019s \u03b2-amyloid fibrils in vitro. Biological Psychiatry, 52(9), 880\u2013886.","journal-title":"Biological Psychiatry"},{"key":"8242_CR66","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1017\/S0317167100037240","volume":"13","author":"EK Perry","year":"1986","unstructured":"Perry, E. K., Perry, R. H., Smith, C. J., Purohit, D., Bonham, J., Dick, D. J., et al. (1986). Cholinergic receptors in cognitive disorders. Canadian Journal of Neurological Sciences, 13, 521\u2013527.","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"8242_CR67","unstructured":"Pettit, D. L., Shao, Z., & Yakel, J. L. (2001). \u03b2-Amyloid(1\u201342) peptide directly modulates nicotinic receptors in the rat hippocampal slice. Journal of Neuroscience 21 (1) RC120, 1\u20135."},{"key":"8242_CR68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-6147(03)00230-X","volume":"24","author":"MR Picciotto","year":"2003","unstructured":"Picciotto, M. R. (2003). Nicotine as modulator of behavior: Beyond the inverted U. Trends in Pharmacological Sciences, 24, 9.","journal-title":"Trends in Pharmacological Sciences"},{"issue":"9","key":"8242_CR69","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00001756-200207020-00006","volume":"13","author":"MR Picciotto","year":"2002","unstructured":"Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J. (2002). Effect of nicotine and nicotinic receptors on anxiety and depression. NeuroReport, 13(9), 1097\u20131106.","journal-title":"NeuroReport"},{"key":"8242_CR70","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/neu.10102","volume":"53","author":"MR Picciotto","year":"2002","unstructured":"Picciotto, M. R., & Zoli, M. (2002). Nicotinic receptors in aging and dementia. Journal of Neurobiology, 53, 641\u2013655.","journal-title":"Journal of Neurobiology"},{"key":"8242_CR71","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3390\/ijms13022219","volume":"13","author":"M Pohanka","year":"2012","unstructured":"Pohanka, M. (2012). \u03b17-nicotinic acetylcholine receptor is a target in pharmacology and toxicology. International Journal of Molecular Sciences, 13, 2219\u20132238.","journal-title":"International Journal of Molecular Sciences"},{"key":"8242_CR72","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.physbeh.2004.10.005","volume":"83","author":"DV Poltavski","year":"2005","unstructured":"Poltavski, D. V., & Petros, T. (2005). Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers. Physiology & Behavior, 83, 833\u2013843.","journal-title":"Physiology & Behavior"},{"issue":"2","key":"8242_CR73","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0006-8993(01)02937-7","volume":"917","author":"M Quik","year":"2001","unstructured":"Quik, M., & Di Monte, D. A. (2001). Nicotine administration reduces striatal MPP+ levels in mice. Brain Research, 917(2), 219\u2013224.","journal-title":"Brain Research"},{"key":"8242_CR74","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0896-6273(00)80134-8","volume":"16","author":"LW Role","year":"1996","unstructured":"Role, L. W., & Berg, D. K. (1996). Nicotinic receptors in the development and modulation of CNS synapses. Neuron, 16, 1077\u20131085.","journal-title":"Neuron"},{"key":"8242_CR75","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1523\/JNEUROSCI.3034-05.2005","volume":"25","author":"F Roselli","year":"2005","unstructured":"Roselli, F., Tirard, M., Lu, J., Hutzler, P., Lamberti, P., Livrea, P., et al. (2005). Soluble \u03b2-amyloid1\u201340 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. Journal of Neuroscience, 25, 11061\u201311070.","journal-title":"Journal of Neuroscience"},{"key":"8242_CR76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nn1374","volume":"8","author":"SB Rosso","year":"2005","unstructured":"Rosso, S. B., Sussman, D., Wynshaw-Brois, A., & Salinas, P. C. (2005). Wnt signaling through Dishevelled, Rac and JNK regulate dendritic development. Nature Neuroscience, 8, 34\u201342.","journal-title":"Nature Neuroscience"},{"key":"8242_CR77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-4328(00)00207-2","volume":"113","author":"JM Rusted","year":"2000","unstructured":"Rusted, J. M., Newhouse, P. A., & Levin, E. D. (2000). Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer\u2019s disease and Parkinson\u2019s disease. Behavioural Brain Research, 113, 121\u2013129.","journal-title":"Behavioural Brain Research"},{"issue":"1\u20133","key":"8242_CR78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2004.08.054","volume":"503","author":"H Sahraei","year":"2004","unstructured":"Sahraei, H., Falahi, M., Zarrindast, M. R., Sabetkasaei, M., Ghoshooni, H., & Khalili, M. (2004). The effects of nitric oxide on the acquisition and expression of nicotine-induced conditioned place preference in mice. European Journal of Pharmacology, 503(1\u20133), 81\u201387.","journal-title":"European Journal of Pharmacology"},{"key":"8242_CR79","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00702-006-0579-2","volume":"113","author":"R Schliebs","year":"2006","unstructured":"Schliebs, R., & Arendt, T. (2006). The significance of the cholinergic system in the brain during aging and in Alzheimer\u2019s disease. Journal of Neural Transmission, 113, 1625\u20131644.","journal-title":"Journal of Neural Transmission"},{"key":"8242_CR80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe, D. J. (2008). Soluble oligomers of the amyloid \u03b2-protein impair synaptic plasticity and behavior. Behavioural Brain Research, 192, 106\u2013113.","journal-title":"Behavioural Brain Research"},{"key":"8242_CR81","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., et al. (2008). Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nature Medicine, 14, 837\u2013842.","journal-title":"Nature Medicine"},{"key":"8242_CR82","doi-asserted-by":"crossref","first-page":"44920","DOI":"10.1074\/jbc.M204610200","volume":"277","author":"S Shaw","year":"2002","unstructured":"Shaw, S., Bencherif, M., & Marrero, M. B. (2002). Janus kinase 2, an early target of \u03b17 nicotinic acetylcholine receptor-mediated neuroprotection against A\u03b2-(1\u201342) amyloid. Journal of Biological Chemistry, 277, 44920\u201344924.","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"8242_CR83","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11373-008-9272-9","volume":"15","author":"N Sood","year":"2008","unstructured":"Sood, N., Sahai, A. K., Medhi, B., & Chakrabarti, A. (2008). Dose-finding study with nicotine as a proconvulsant agent in PTZ-induced seizure model in mice. Journal of Biomedical Science, 15(6), 755\u2013765.","journal-title":"Journal of Biomedical Science"},{"key":"8242_CR84","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1152\/physrev.00034.2007","volume":"88","author":"SF Steinberg","year":"2008","unstructured":"Steinberg, S. F. (2008). Structural basis of protein kinase C isoform function. Physiological Reviews, 88, 1341\u20131378.","journal-title":"Physiological Reviews"},{"key":"8242_CR85","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D., Masliah, E., Slamon, D. P., Betters, N., De Teresa, R., Hill, R., et al. (1991). Physical basis of cognitive alterations in Alzheimer\u2019s disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology, 30, 572\u2013580.","journal-title":"Annals of Neurology"},{"key":"8242_CR86","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/mp.2009.72","volume":"15","author":"EM Toledo","year":"2010","unstructured":"Toledo, E. M., & Inestrosa, N. C. (2010). Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe\/PSEN1DeltaE9 mouse model of Alzheimer\u2019s disease. Molecular Psychiatry, 15, 272\u2013285.","journal-title":"Molecular Psychiatry"},{"key":"8242_CR120","doi-asserted-by":"crossref","unstructured":"Varela-Nallar, L., Alfaro, I. E., Serrano, F. G., Parodi, J., & Inestrosa, N. C. (2010). Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proceedings of the National Academy of Sciences, 107(49), 21164\u201321169.","DOI":"10.1073\/pnas.1010011107"},{"key":"8242_CR87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0896-6273(92)90114-S","volume":"8","author":"S Vernino","year":"1992","unstructured":"Vernino, S., Amador, M., Luetje, C. W., Patrick, J., & Dani, J. A. (1992). Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron, 8, 127\u2013134.","journal-title":"Neuron"},{"key":"8242_CR88","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1097-2765(05)00089-4","volume":"6","author":"EH Walker","year":"2000","unstructured":"Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P., Wymann, M. P., et al. (2000). Structural determinants of phosphoinositide 3-kinase inhibition by wortaminn, LY294002, quercetin, myricetin and staurosporine. Molecular Cell, 6, 909\u2013919.","journal-title":"Molecular Cell"},{"key":"8242_CR89","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., et al. (2002). Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 416, 535\u2013539.","journal-title":"Nature"},{"key":"8242_CR90","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh, D. M., & Selkoe, D. J. (2007). A\u03b2 oligomers\u2014A decade of discovery. Journal of Neurochemistry, 101, 1172\u20131184.","journal-title":"Journal of Neurochemistry"},{"key":"8242_CR91","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1523\/JNEUROSCI.4391-04.2005","volume":"25","author":"DM Walsh","year":"2005","unstructured":"Walsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., El Agnaf, O., et al. (2005). Certain inhibitors of synthetic amyloid \u03b2-peptide (A\u03b2) fibrillogenesis block oligomerization of natural A\u03b2 and thereby rescue long-term potentiation. Journal of Neuroscience, 25, 2455\u20132462.","journal-title":"Journal of Neuroscience"},{"issue":"8","key":"8242_CR92","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","volume":"275","author":"HY Wang","year":"2000","unstructured":"Wang, H. Y., Lee, D. H., D\u2019Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000). \u03b2-amyloid(1\u201342) binds to \u03b17-nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer\u2019s disease pathology. Journal of Biological Chemistry, 275(8), 5626\u20135632.","journal-title":"Journal of Biological Chemistry"},{"key":"8242_CR93","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1523\/JNEUROSCI.6088-08.2009","volume":"29","author":"HY Wang","year":"2009","unstructured":"Wang, H. Y., Stucky, A., Liu, J., Shen, C., Trocme-Thibierge, C., & Morain, P. (2009). Dissociating \u03b2-amyloid from \u03b17 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes \u03b17-nicotinic acetylcholine and NMDA receptor function in Alzheimer\u2019s disease brain. Journal of Neuroscience, 29, 10961\u201310973.","journal-title":"Journal of Neuroscience"},{"key":"8242_CR94","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"215","author":"PJ Whitehouse","year":"1982","unstructured":"Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A. W., Coyle, J. T., & Delon, M. R. (1982). Alzheimer\u2019s disease and senile dementia: Loss of neurons in the basal forebrain. Science, 215, 1237\u20131239.","journal-title":"Science"},{"key":"8242_CR95","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/nn1132","volume":"6","author":"X Yu","year":"2003","unstructured":"Yu, X., & Malenka, R. C. (2003). \u03b2\u2013catenin is critical for dendritic morphogenesis. Nature Neuroscience, 6, 1169\u20131177.","journal-title":"Nature Neuroscience"},{"issue":"1","key":"8242_CR96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(95)00628-1","volume":"295","author":"MR Zarrindast","year":"1996","unstructured":"Zarrindast, M. R., Sadegh, M., & Shafaghi, B. (1996). Effects of nicotine on memory retrieval in mice. European Journal of Pharmacology, 295(1), 1\u20136.","journal-title":"European Journal of Pharmacology"},{"key":"8242_CR97","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/emboj\/18.5.1235","volume":"18","author":"M Zoli","year":"1999","unstructured":"Zoli, M., Picciotto, M. R., Ferrari, R., Cocchi, D., & Changeux, J. P. (1999). Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. The EMBO Journal, 18, 1235\u20131244.","journal-title":"The EMBO Journal"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-013-8242-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-013-8242-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-013-8242-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T22:10:45Z","timestamp":1563401445000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-013-8242-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,11]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["8242"],"URL":"https:\/\/doi.org\/10.1007\/s12017-013-8242-1","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,11]]}}}